Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003554914 | SCV004292038 | pathogenic | not provided | 2023-12-20 | criteria provided, single submitter | clinical testing | This variant, c.670_672del, results in the deletion of 1 amino acid(s) of the TPO protein (p.Asp224del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs772164623, gnomAD 0.08%). This variant has been observed in individual(s) with clinical features of thyroid dyshormonogenesis (PMID: 25564141, 28867693, 32078117, 32088313). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this variant affects TPO function (PMID: 28867693, 32078117). For these reasons, this variant has been classified as Pathogenic. |
Juno Genomics, |
RCV004796820 | SCV005418349 | likely pathogenic | Deficiency of iodide peroxidase | criteria provided, single submitter | clinical testing | PM2_Supporting+PM3_Strong+PP4+PM4 | |
Fulgent Genetics, |
RCV004796820 | SCV005652935 | pathogenic | Deficiency of iodide peroxidase | 2024-06-22 | criteria provided, single submitter | clinical testing |